Topical corticosteroid therapy in psoriasis vulgaris: update and new strategies.
This is an update of a previous report on the use of topical steroids in the management of psoriasis vulgaris. The current focus is on new combination therapies that enhance the efficacy of corticosteroids while diminishing their potential side effects.
Trozak
D J
DJ
Psoriasis Research Institute, Palo Alto, California, USA.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives; D003879:Dermatologic Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005938:Glucocorticoids; D006801:Humans; D009539:Nicotinic Acids / Q000008:administration & dosage; D011239:Prednisolone / Q000031:analogs & derivatives; D011565:Psoriasis / Q000188:drug therapy*; D012176:Retinoids
D000893:Anti-Inflammatory Agents; D002117:Calcitriol; D003879:Dermatologic Agents; D005938:Glucocorticoids; D009539:Nicotinic Acids; D011239:Prednisolone; C055085:calcipotriene; C086827:tazarotene; D012176:Retinoids; C035287:prednicarbate